ArticleJournal of nanobiotechnology2025

Co-delivery of axitinib and PD-L1 siRNA for the synergism of vascular normalization and immune checkpoint inhibition to boost anticancer immunity.

Yanhong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.